skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Mostrar Somente
Refinado por: Base de dados/Biblioteca: Publisher or Other Site remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Use of a nanocrystalline silver dressing on lymphatic ulcers in patients with chronic lymphoedema
Use of a nanocrystalline silver dressing on lymphatic ulcers in patients with chronic lymphoedema
Material Type:
Artigo 		Adicionar ao Meu Espaço

Use of a nanocrystalline silver dressing on lymphatic ulcers in patients with chronic lymphoedema

Forner-Cordero, I ; Navarro-Monsoliu, R ; Muñoz-Langa, J ; Alcober-Fuster, P ; Rel-Monzó, P

Journal of wound care, 2007-05, Vol.16 (5), p.235-239 [Periódico revisado por pares]

London: MA Healthcare

Texto completo disponível

Citações Citado por
2
Training medical assistants for surgery
Training medical assistants for surgery
Material Type:
Artigo 		Adicionar ao Meu Espaço

Training medical assistants for surgery

VAZ, F ; BERGSTRÖM, S ; DA LUZ VAZ, M ; LANGA, J ; BUGALHO, A

Bulletin of the World Health Organization, 1999-01, Vol.77 (8), p.688-691 [Periódico revisado por pares]

Genève: Organisation mondiale de la santé

Texto completo disponível

Citações Citado por
3
The dimension of attractors of nonautonomous partial differential equations
The dimension of attractors of nonautonomous partial differential equations
Material Type:
Artigo 		Adicionar ao Meu Espaço

The dimension of attractors of nonautonomous partial differential equations

Caraballo, T. ; Langa, J. A. ; Valero, J.

The ANZIAM journal, 2003-10, Vol.45 (2), p.207-222 [Periódico revisado por pares]

Cambridge, UK: Cambridge University Press

Texto completo disponível

Citações Citado por
4
Phase II trial of temozolomide for leptomeningeal metastases: Safety and activity analysis
Phase II trial of temozolomide for leptomeningeal metastases: Safety and activity analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II trial of temozolomide for leptomeningeal metastases: Safety and activity analysis

Pérez Segura, P. ; Gil, M. ; Balañá, C. ; Chacón, I. ; Muñoz Langa, J. ; Martin, M.

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e12528-e12528 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
5
A multicenter, open, randomized, phase II study to investigate the sequential administration of docetaxel and intermittent erlotinib versus erlotinib as a second-line therapy for advanced non-small cell lung cancer (NSCLC)
A multicenter, open, randomized, phase II study to investigate the sequential administration of docetaxel and intermittent erlotinib versus erlotinib as a second-line therapy for advanced non-small cell lung cancer (NSCLC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

A multicenter, open, randomized, phase II study to investigate the sequential administration of docetaxel and intermittent erlotinib versus erlotinib as a second-line therapy for advanced non-small cell lung cancer (NSCLC)

Aparisi, F. ; Garcia Sanchez, J. ; Sanchez-Hernandez, A. ; Giner, V. ; Muñoz-Langa, J. ; Esquerdo, G. ; López Jiménez, A. ; Garde, J. ; Juan Vidal, O.

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e18036-e18036 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
6
Phase II study of bevacizumab in combination with cisplatin and docetaxel as first-line treatment of patients (p) with metastatic non-squamous non-small cell lung cancer (NSCLC): Final report
Phase II study of bevacizumab in combination with cisplatin and docetaxel as first-line treatment of patients (p) with metastatic non-squamous non-small cell lung cancer (NSCLC): Final report
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II study of bevacizumab in combination with cisplatin and docetaxel as first-line treatment of patients (p) with metastatic non-squamous non-small cell lung cancer (NSCLC): Final report

Cobo, M. ; Ferrer, N. ; Paredes, A. ; Mendez, M. ; Muñoz-Langa, J. ; Rueda, A. ; Alvarez De Mon, M. ; Sanchez-Hernandez, A. ; Gallego, R. ; Torrego, J.

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e18009-e18009 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
7
Assessing adherence to the European Organization for Research and Treatment of Cancer (EORTC) guidelines for the use of erythropoiesis-stimulating agents in cancer patients
Assessing adherence to the European Organization for Research and Treatment of Cancer (EORTC) guidelines for the use of erythropoiesis-stimulating agents in cancer patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Assessing adherence to the European Organization for Research and Treatment of Cancer (EORTC) guidelines for the use of erythropoiesis-stimulating agents in cancer patients

Castro, J. ; Muñoz-Langa, J. M. ; Covas, A. ; Gasquet, J. A.

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.20696-20696 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
8
Phase II study of bevacizumab in combination with cisplatin and docetaxel as first-line treatment of patients (p) with metastatic non-squamous non-small cell lung cancer (NSCLC)
Phase II study of bevacizumab in combination with cisplatin and docetaxel as first-line treatment of patients (p) with metastatic non-squamous non-small cell lung cancer (NSCLC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II study of bevacizumab in combination with cisplatin and docetaxel as first-line treatment of patients (p) with metastatic non-squamous non-small cell lung cancer (NSCLC)

Ferrer, N. ; Cobo, M. ; Paredes, A. ; Méndez, M. ; Muñoz-Langa, J. ; Rueda, A. ; Álvarez de Mon, M. ; Sánchez-Hernández, A. ; Gallego, R. ; Torrego, J.

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e19023-e19023 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
9
Cisplatin (CDDP) plus vinorelbine (NVB) as first-line treatment for advanced non-small-cell lung cancer (NSCLC): Retrospective analysis to improve the patient’s convenience on day 8 NVB administration
Cisplatin (CDDP) plus vinorelbine (NVB) as first-line treatment for advanced non-small-cell lung cancer (NSCLC): Retrospective analysis to improve the patient’s convenience on day 8 NVB administration
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cisplatin (CDDP) plus vinorelbine (NVB) as first-line treatment for advanced non-small-cell lung cancer (NSCLC): Retrospective analysis to improve the patient’s convenience on day 8 NVB administration

Provencio, M. ; de las Peñas, R. ; Cobo, M. ; Massuti, B. ; Artal, A. ; Muñoz-Langa, J. M. ; Garcia-Gomez, R. ; Sanchez- Ruiz, A. ; Rosell, R.

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.19049-19049 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
10
Bevacizumab in combination with cisplatin and docetaxel as first line treatment of patients (pts) with advanced or metastatic, non squamous, non-small-cell lung cancer (NSCLC)
Bevacizumab in combination with cisplatin and docetaxel as first line treatment of patients (pts) with advanced or metastatic, non squamous, non-small-cell lung cancer (NSCLC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bevacizumab in combination with cisplatin and docetaxel as first line treatment of patients (pts) with advanced or metastatic, non squamous, non-small-cell lung cancer (NSCLC)

Ferrer, N. ; Paredes, A. ; Muñoz-Langa, J. M. ; Mendez, M. ; Cobo, M. ; de-Portugal, T. ; Giner, V. ; Garcia, S. ; Gallego, R. ; Torrego, J.

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.19109-19109 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (12)

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.